India, Oct. 31 -- BD (Becton, Dickinson and Company) India has announced the national launch of Sherlock 3CG+ recently through a 4-city roadshow in Delhi, Mumbai, Chennai and Kolkata. In current Indian clinical practice, typically for cancer patients and long term IV access, confirming PICC tip placement involves transferring patients for radiological imaging, which can lead to delays, workflow disruptions, and patient discomfort.
Sherlock 3CG+ addresses these challenges by allowing clinicians to live track and navigate PICC lines and confirm tip placement in real time, directly at the bedside. This advancement is expected to reduce malposition rates and enable immediate repositioning when necessary.
Global clinical evidence has shown mal...